Business · India Bureau
ED seizes assets in Bengaluru counterfeit drug racket investigation
The Enforcement Directorate has attached assets and frozen bank accounts as part of a crackdown on an alleged counterfeit medicines operation in Bengaluru. Searches across five premises uncovered unlicensed pharmaceutical storage and deliberate relabeling of drugs.
LSN India ·

The Enforcement Directorate has taken action against an alleged counterfeit medicines racket operating in Bengaluru, freezing bank accounts and attaching assets as part of an ongoing investigation. The federal agency conducted searches at five premises in the city as part of the enforcement action.
During the raids, investigators discovered significant contraventions of pharmaceutical regulations. Authorities alleged that accused parties were storing medicines and pharmaceutical drugs without requisite licenses, permits, or authorizations. The searches also revealed evidence of systematic label replacement on stored medicines, suggesting an organized attempt to misrepresent products in the market.
The operation highlights growing concerns over the distribution of counterfeit pharmaceuticals in India. Such unlicensed operations pose significant public health risks, as counterfeit drugs can be ineffective, contaminated, or contain harmful substances that endanger consumers.
The ED's asset attachment and account freezing represent preliminary enforcement measures as the investigation proceeds. Authorities have not yet disclosed further details regarding the scale of the operation or the individuals involved.